Evidence map›Paper›PMID 40535107›Full record

ArticleComputational and structural biotechnology journal2025

Class-agnostic annotation of small RNAs balances sensitivity and specificity in diverse organisms.

Nathan R Johnson, Fabian Gonzalez-Toro, Barbara Bernal Gomez

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nathan R JohnsonCentro de Genómica y Bioinformática, Facultad de Ciencias, Ingeniería y Tecnología, Universidad Mayor, Chile.
Fabian Gonzalez-ToroCentro de Genómica y Bioinformática, Facultad de Ciencias, Ingeniería y Tecnología, Universidad Mayor, Chile.
Barbara Bernal GomezCentro de Genómica y Bioinformática, Facultad de Ciencias, Ingeniería y Tecnología, Universidad Mayor, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small RNAs (sRNAs) are important regulatory elements in eukaryotic organisms and comprise the functional elements of RNA interference. Numerous classes of sRNAs have been annotated, however they vary greatly in their ease of annotation and compatibility with most annotators. Significant challenges exist for the annotation process, including variation in sRNA library quality, alignment depth, and poorly defined loci, collectively making this process difficult. Additionally, few annotators are fully agnostic to sRNA classes and may struggle identifying loci in less explored organisms. To address these problems, we present the annotation tool YASMA-tradeoff (YTO), which is specifically suited to finding reliable thresholds for locus annotation which balance sensitivity with specificity. We compared YTO with other annotators, we show that it and other pipelines based on coverage-normalization methods have great advantages, balancing many metrics to produce a more reproducible annotation. We also demonstrate that YTO produces more contiguous and representative loci, through the aggressive merging of similar expressed regions. Finally, we also show that the tool produces much more descriptive locus dimensions, a major advantage in species where sRNAs may be distinct or unique. Overall, we demonstrate substantial improvements in annotation accuracy, reproducibility, and description, particularly in non-model organisms and less-explored clades.

Indexed as

EukaryotesMiRNAsNon-model organismsPiRNAsSiRNAsTinyRNAsTotal small RNAs

Identifiers

PMID40535107
PMCPMC12174571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.